FENOFIBRATE (MICRONIZED) Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Fenofibrate (micronized), and what generic alternatives are available?
Fenofibrate (micronized) is a drug marketed by Ajanta Pharma Ltd, Alembic, Ani Pharms, Apotex, Aurobindo Pharma Ltd, Chartwell, Dr Reddys Labs Sa, Glenmark Pharms Ltd, Impax Labs, Invagen Pharms, Norvium Bioscience, Novast Labs, Reyoung, Rhodes Pharms, Rising, and Torrent. and is included in sixteen NDAs.
The generic ingredient in FENOFIBRATE (MICRONIZED) is fenofibrate. There are forty-two drug master file entries for this compound. Fifty-four suppliers are listed for this compound. Additional details are available on the fenofibrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Fenofibrate (micronized)
A generic version of FENOFIBRATE (MICRONIZED) was approved as fenofibrate by RHODES PHARMS on May 13th, 2005.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for FENOFIBRATE (MICRONIZED)?
- What are the global sales for FENOFIBRATE (MICRONIZED)?
- What is Average Wholesale Price for FENOFIBRATE (MICRONIZED)?
Summary for FENOFIBRATE (MICRONIZED)
US Patents: | 0 |
Applicants: | 16 |
NDAs: | 16 |
Finished Product Suppliers / Packagers: | 17 |
Raw Ingredient (Bulk) Api Vendors: | 138 |
Clinical Trials: | 7 |
Patent Applications: | 4,099 |
DailyMed Link: | FENOFIBRATE (MICRONIZED) at DailyMed |